Data is being updated
Roll-call votes · EU Parliament
How Jorge voted.
Plenary sitting today: 7 October 2026
Jorge Buxadé Villalba
Spain ES
Speeches 175
Mandate 2024–2029
Voting Pattern –
Loading…
– – – –
Unable to load stats
Legislative record 11 documents
Joint motions
1 9.1%
Reports
0 0.0%
Motions
10 90.9%

Jorge Buxadé Villalba (PfE, Spain) — 2324 Roll-call votes · EU Parliament: 886 For (38.1%), 1026 Against (44.1%), 385 Abstention (16.6%), 27 Did not vote (1.2%).

Roll-call votes · EU Parliament

How Jorge Buxadé Villalba voted.

Plenary sitting today: 7 October 2026
Motion adopted

Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795 (Motion adopted): 503 For, 57 Against, 108 Abstention, 67 Did not vote (735 Members). Jorge Buxadé Villalba: Against.

20 Jan
2026
20. Jan 2026 · A10-0272/2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
A10-0272/2025
My vote Against
For
503
Motion rejected

Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795 (Motion rejected): 44 For, 600 Against, 13 Abstention, 78 Did not vote (735 Members). Jorge Buxadé Villalba: Abstention.

20 Jan
2026
20. Jan 2026 · A10-0272/2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
A10-0272/2025
My vote Abstention
Against
600
Motion adopted

Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006 (Motion adopted): 488 For, 67 Against, 34 Abstention, 224 Did not vote (813 Members). Jorge Buxadé Villalba: Abstention.

10 Apr
2024
10. Apr 2024 · A9-0141/2024
Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
A9-0141/2024
My vote Abstention
For
488
Showing 3 of 3
Follow us on Instagram @checksomevotes @checksomevotes_en